ArticlePathology oncology research : POR2021

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy.

Shirong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.